Subject(s)
Humans , Female , Aged , Multiple Myeloma/drug therapy , Antineoplastic Agents, Immunological/adverse effects , Antineoplastic Agents, Immunological/therapeutic use , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/therapy , Desensitization, Immunologic , Severity of Illness IndexABSTRACT
VIII Updating Course of Antimicrobials and Infectious Diseases has reviewed useful microbiological, epidemiological and clinical aspects for a current approach of infectious pathology. Present manuscript summarizes a chronicle about the main infection related meetings during 2017 (ECCMID, IAS, ASM and ID Week). In addition, the course proposed a practical approach for understanding different type of pathogens and our selected topics this year were the epidemiology of bacterial nosocomial infection, a practical approach to Clostridium difficile infection patients, a two year selection of the top ten papers about fungal infection and an update in fungal biofilms. Finally, proffesors made a practical approach by main clinical syndromes like sepsis, infections in oncohematological patients, CNS infections in immunosuppressed patients and reviewed the top ten papers in transplant infectious diseases and infection control during the last two years.
Subject(s)
Anti-Infective Agents/therapeutic use , Communicable Diseases/drug therapy , Communicable Diseases/microbiology , HumansABSTRACT
OBJECTIVE: To find the prevalence of hepatitis C virus infection. DESIGN: Cross sectional study. SETTING: School children of the Autonomous Community of Madrid. PATIENTS AND OTHER PARTICIPANTS: 560 school children of 4 and 17 years-old. MEASUREMENTS AND MAIN RESULTS: ELISA II the anti-HCV appeared in 0,36% of population. CONCLUSIONS: Our prevalence is the same a other studies and we think that it haven't different factors in our community different of others with a similar prevalence in adults population.
